ERYZYME

Product Candidate / Program Drug substance Indication Discovery Pre-clinical Phase I Phase II Phase III / Pivotal
ERYZYME Therapeutic enzymes Metabolic diseases  

ERYZYME covers the application of our ERYCAPS platform to enzyme-based therapies beyond oncology. As with our lead program eryaspase, we encapsulate therapeutic enzymes in red blood cells to deliver superior outcomes through long-acting efficacy and reduced adverse reaction vs. non-encapsulated enzymes.

Under the ERYZYME approach, Erytech is currently advancing a pipeline of novel and highly differentiated programs for rare and highly specialized conditions.

Top